Application of the interferon minipellet to human renal cell carcinoma in nude mice

Ken Marumo, Mototsugu Oya, Masaru Murai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: The interferon (IFN) minipellet is a sustained-release formulation of human lymphoblastoid IFN, with atelocollagen used as the carrier material. We evaluated the antitumor effect of the IFN minipellet on an established human renal cell carcinoma cell line (KU-2) transplanted in nude mice. Methods: The treatment was started when tumor nodules had grown to 6 to 8 mm in diameter. The IFN minipellet, or an aqueous solution of IFN, was given by subcutaneous injection, or peritumor injection, on days 1 and 10. Antitumor effects were evaluated according to tumor weights calculated as (long diameter) x (short diameter)2/2 in 7 groups consisting of 6 mice each. Results: IFN levels remained detectable in both tumor tissue and serum up to in days after peritumor injection of the IFN minipellet. Administered by the peritumor route, the IFN minipellet inhibited growth of the tumor significantly as compared with tumor growth in the untreated mice. The IFN minipellet showed greater inhibition of tumor growth by peritumor injection compared to subcutaneous injection. The aqueous solution of IFN was not effective either by subcutaneous or by peritumoral injection. Conclusion: Results indicate that the IFN minipellet is useful in the treatment of renal cell carcinoma.

Original languageEnglish
Pages (from-to)55-61
Number of pages7
JournalInternational Journal of Urology
Volume4
Issue number1
Publication statusPublished - 1997

Fingerprint

Renal Cell Carcinoma
Nude Mice
Interferons
Injections
Subcutaneous Injections
Neoplasms
Growth
Tumor Burden
Interferon-alpha
Cell Line
Therapeutics
Serum

Keywords

  • Collagen
  • Drug delivery system
  • Interferon minipellet
  • Nude mouse
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Application of the interferon minipellet to human renal cell carcinoma in nude mice. / Marumo, Ken; Oya, Mototsugu; Murai, Masaru.

In: International Journal of Urology, Vol. 4, No. 1, 1997, p. 55-61.

Research output: Contribution to journalArticle

@article{5824bf504ee644459c578952871db2b9,
title = "Application of the interferon minipellet to human renal cell carcinoma in nude mice",
abstract = "Background: The interferon (IFN) minipellet is a sustained-release formulation of human lymphoblastoid IFN, with atelocollagen used as the carrier material. We evaluated the antitumor effect of the IFN minipellet on an established human renal cell carcinoma cell line (KU-2) transplanted in nude mice. Methods: The treatment was started when tumor nodules had grown to 6 to 8 mm in diameter. The IFN minipellet, or an aqueous solution of IFN, was given by subcutaneous injection, or peritumor injection, on days 1 and 10. Antitumor effects were evaluated according to tumor weights calculated as (long diameter) x (short diameter)2/2 in 7 groups consisting of 6 mice each. Results: IFN levels remained detectable in both tumor tissue and serum up to in days after peritumor injection of the IFN minipellet. Administered by the peritumor route, the IFN minipellet inhibited growth of the tumor significantly as compared with tumor growth in the untreated mice. The IFN minipellet showed greater inhibition of tumor growth by peritumor injection compared to subcutaneous injection. The aqueous solution of IFN was not effective either by subcutaneous or by peritumoral injection. Conclusion: Results indicate that the IFN minipellet is useful in the treatment of renal cell carcinoma.",
keywords = "Collagen, Drug delivery system, Interferon minipellet, Nude mouse, Renal cell carcinoma",
author = "Ken Marumo and Mototsugu Oya and Masaru Murai",
year = "1997",
language = "English",
volume = "4",
pages = "55--61",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Application of the interferon minipellet to human renal cell carcinoma in nude mice

AU - Marumo, Ken

AU - Oya, Mototsugu

AU - Murai, Masaru

PY - 1997

Y1 - 1997

N2 - Background: The interferon (IFN) minipellet is a sustained-release formulation of human lymphoblastoid IFN, with atelocollagen used as the carrier material. We evaluated the antitumor effect of the IFN minipellet on an established human renal cell carcinoma cell line (KU-2) transplanted in nude mice. Methods: The treatment was started when tumor nodules had grown to 6 to 8 mm in diameter. The IFN minipellet, or an aqueous solution of IFN, was given by subcutaneous injection, or peritumor injection, on days 1 and 10. Antitumor effects were evaluated according to tumor weights calculated as (long diameter) x (short diameter)2/2 in 7 groups consisting of 6 mice each. Results: IFN levels remained detectable in both tumor tissue and serum up to in days after peritumor injection of the IFN minipellet. Administered by the peritumor route, the IFN minipellet inhibited growth of the tumor significantly as compared with tumor growth in the untreated mice. The IFN minipellet showed greater inhibition of tumor growth by peritumor injection compared to subcutaneous injection. The aqueous solution of IFN was not effective either by subcutaneous or by peritumoral injection. Conclusion: Results indicate that the IFN minipellet is useful in the treatment of renal cell carcinoma.

AB - Background: The interferon (IFN) minipellet is a sustained-release formulation of human lymphoblastoid IFN, with atelocollagen used as the carrier material. We evaluated the antitumor effect of the IFN minipellet on an established human renal cell carcinoma cell line (KU-2) transplanted in nude mice. Methods: The treatment was started when tumor nodules had grown to 6 to 8 mm in diameter. The IFN minipellet, or an aqueous solution of IFN, was given by subcutaneous injection, or peritumor injection, on days 1 and 10. Antitumor effects were evaluated according to tumor weights calculated as (long diameter) x (short diameter)2/2 in 7 groups consisting of 6 mice each. Results: IFN levels remained detectable in both tumor tissue and serum up to in days after peritumor injection of the IFN minipellet. Administered by the peritumor route, the IFN minipellet inhibited growth of the tumor significantly as compared with tumor growth in the untreated mice. The IFN minipellet showed greater inhibition of tumor growth by peritumor injection compared to subcutaneous injection. The aqueous solution of IFN was not effective either by subcutaneous or by peritumoral injection. Conclusion: Results indicate that the IFN minipellet is useful in the treatment of renal cell carcinoma.

KW - Collagen

KW - Drug delivery system

KW - Interferon minipellet

KW - Nude mouse

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030930927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030930927&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 55

EP - 61

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 1

ER -